Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Summary: Childhood‐onset growth hormone deficiency (GHD) is frequently perceived to cause low bone density, fractures and osteoporosis. This article critically reviews the evidence behind these perceptions. Inherent limitations of current bone imaging techniques have caused many artefacts and misconceptions about bone density and structure. Using appropriate size‐corrections, bone density is normal in children and adults with isolated GHD. Cortical density, trabecular density and trabecular volume are normal when measured by peripheral quantitative computerized tomography and histomorphometry. The only verifiable deficit affects cortical thickness (periosteal expansion), both in human and animal studies. However, short limb bones cannot be expected to have an average‐sized shaft, as bone elongation and widening could be proportionally impaired in GHD. In addition, GH and IGF‐1 have indisputable anabolic actions not only on bone, but also on muscle tissue. In fact, compared with all other bone‐related variables, muscle size is the lowest at diagnosis of GHD. During GH therapy, muscle enlargement precedes and exceeds any gain in bone mass. The mechanostat theory suggests that the GHD‐induced deficit in muscle force secondarily causes low cortical thickness. There is no evidence that isolated childhood‐onset GHD, or severe GH resistance, causes an increased fracture risk in children or adults. Only adults with organic hypopituitarism appear to have a slightly greater risk of fractures. Using current transition guidelines, short children and adults with GHD are at risk of being misdiagnosed with low bone mass and may consequently receive inappropriate treatment. As neither reports of increased fracture risk nor low bone density can stand up against scrutiny, these misconceptions should no longer influence clinical practice. In this respect, GHD should not be listed as a cause of osteoporosis in children and there is a need to review current transition guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Circulating levels of IGF-1 directly regulate bone growth and density
Yakar, S., Rosen, C. J., Beamer, W. G., Ackert-Bicknell, C. L., Wu, Y., Liu, J.-L., Ooi, G. T., Setser, J., Frystyk, J., Boisclair, Y. R., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215463 · Cited by 739
Baim, S., Binkley, N., Bilezikian, J. P., Kendler, D. L., Hans, D. B., Lewiecki, E. M., & Silverman, S. (2008) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2007.12.007 · Cited by 418
Consensus statement on the management of the GH-treated adolescent in the transition to adult care
Clayton, P. E., Cuneo, R. C., Juul, A., Monson, J. P., Shalet, S. M., & Tauber, M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01829 · Cited by 270
Wüster, C., Abs, R., Bengtsson, B.-Å., Bennmarker, H., Feldt-Rasmussen, U., Hernberg-Ståhl, E., Monson, J. P., Westberg, B., & Wilton, P. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.2.398 · Cited by 267
On the estrogen-bone relationship and postmenopausal bone loss: a new model
Frost, H. M. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.9.1473 · Cited by 164
Mazziotti, G., Bianchi, A., Bonadonna, S., Nuzzo, M., Cimino, V., Fusco, A., De Marinis, L., & Giustina, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060112 · Cited by 141
Vestergaard, P., Jørgensen, J. O. L., Hagen, C., Hoeck, H. C., Laurberg, P., Rejnmark, L., Brixen, K., Weeke, J., Andersen, M., Conceicao, F. L., et al. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01464.x · Cited by 99
Abs, R., Mattsson, A. F., Bengtsson, B.-Å., Feldt-Rasmussen, U., Góth, M. I., Koltowska-Häggström, M., Monson, J. P., Verhelst, J., & Wilton, P. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.06.018 · Cited by 91
Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults
Götherström, G., Elbornsson, M., Stibrant-Sunnerhagen, K., Bengtsson, B.-A., Johannsson, G., & Svensson, J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1538 · Cited by 85
Fracture Incidence in GH-Deficient Patients on Complete Hormone Replacement Including GH
Holmer, H., Svensson, J., Rylander, L., Johannsson, G., Rosén, T., Bengtsson, B.-Å., Thorén, M., Höybye, C., Degerblad, M., Bramnert, M., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070811 · Cited by 66
Cited by
Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Mazziotti, G., Chiavistelli, S., & Giustina, A. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.10.014 · Cited by 46
Pituitary Disorders and Osteoporosis
Bolanowski, M., Halupczok, J., & Jawiarczyk-Przybyłowska, A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/206853 · Cited by 30
Metadata
- Authors
- Högler, W., & Shaw, N.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2010-02-10
- Volume
- 72
- Issue
- 3
- Pages
- 281-289
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1986642689
- Cited by
- 95
- References
- 10
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. https://app.cochat.ai/papers/10.1111/j.1365-2265.2009.03686.x
- The paper
- Högler, W., & Shaw, N. (2010). Childhood growth hormone deficiency, bone density, structures and fractures: scrutinizing the evidence. Clinical Endocrinology. https://doi.org/10.1111/j.1365-2265.2009.03686.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.